Tirzepatide Alternatives: Semaglutide, Brand vs Compounded, and Lifestyle

FormBlends Editorial Research. Last reviewed September 9, 2026 against the Zepbound and Mounjaro prescribing information and the trial publications listed under Sources.

The closest drug to tirzepatide is semaglutide, sold as Wegovy and Ozempic. No pill or store product does the same job. If cost is the issue, your real choices are brand Zepbound, compounded tirzepatide, or compounded semaglutide. In the one head-to-head trial, tirzepatide won on weight loss. New to the drug? Read our tirzepatide guide first.

Key takeaways

• Semaglutide is the nearest prescription alternative; it works on one receptor (GLP-1) while tirzepatide works on two (GLP-1 and GIP).
• In SURMOUNT-5, tirzepatide produced a 20.2% mean weight loss versus 13.7% for semaglutide at 72 weeks.
• In SURPASS-2, tirzepatide beat semaglutide 1 mg on both A1c and weight in adults with type 2 diabetes.
• No over-the-counter product contains tirzepatide, and no supplement has been tested against it.
• Compounded tirzepatide and compounded semaglutide are not FDA approved and are not interchangeable with the branded drugs.

Is there a tirzepatide alternative over the counter?

No. Tirzepatide is a prescription drug, and so is semaglutide. Products sold in stores or online as "natural Zepbound," "GLP-1 boosters" or "fit pills" do not contain tirzepatide and have not been tested in trials like SURMOUNT or SURPASS. A vendor that ships tirzepatide vials without a prescription is a gray market seller, not an over-the-counter option; the FDA has warned about unapproved GLP-1 products from such sources. If a product needs no prescription, it is not tirzepatide.

The closest medical alternative: semaglutide

Semaglutide and tirzepatide are both once-weekly injections that lower appetite and slow stomach emptying. The difference is the receptor list. Semaglutide activates the GLP-1 receptor. Tirzepatide activates the GLP-1 receptor and the GIP receptor. The only head-to-head trial in obesity, SURMOUNT-5, compared the two in adults with obesity without diabetes over 72 weeks.

Source: SURMOUNT-5, Aronne et al., NEJM 2025.

In type 2 diabetes, SURPASS-2 compared three tirzepatide doses with semaglutide 1 mg over 40 weeks.

Source: SURPASS-2, Frias et al., NEJM 2021.

Semaglutide is still a strong drug. Its 13.7% in SURMOUNT-5 is far above the 3.1% seen with placebo in SURMOUNT-1. For some people it is the better fit because they tolerate it better, because their insurance covers it, or because a prescriber prefers it for a specific reason. That choice belongs to you and your prescriber.

Brand tirzepatide versus compounded tirzepatide

If tirzepatide is the drug you want and price is the barrier, the alternative is often a different route to the same molecule rather than a different molecule. Zepbound and Mounjaro are the FDA-approved products. Compounded tirzepatide is made per prescription by state-licensed 503A compounding pharmacies; it is not FDA approved and not interchangeable with the branded drugs, and it has no trial data of its own. Here is what the two routes cost.

Source: FormBlends pricing (verified September 5, 2026); Eli Lilly LillyDirect self-pay pricing (accessed September 4, 2026).

See the pricing page for 3, 6 and 12 month plans. Lab work is not included in any FormBlends plan.

Can diet and exercise replace tirzepatide?

Lifestyle change is part of every tirzepatide plan; both labels say the drug is an adjunct to a reduced-calorie diet and increased physical activity. The trials also show what lifestyle alone did in the same setting. In SURMOUNT-3, everyone completed a 12-week intensive lifestyle program first. Over the next 72 weeks, those who added tirzepatide lost a further 18.4% of body weight, while those on placebo with the same lifestyle support gained 2.5%. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained 14.0% over the following 52 weeks, while those who continued lost a further 5.5%.

Source: SURMOUNT-1 (Jastreboff et al., NEJM 2022), SURMOUNT-3 (Wadden et al., Nat Med 2023), SURMOUNT-4 (Aronne et al., JAMA 2024).

Those numbers do not mean lifestyle change is useless. They mean that in these trials, lifestyle support on its own did not produce the weight loss that the drug plus lifestyle did. Whether you should use a drug at all is a conversation for you and a clinician.

What this means for compounded tirzepatide

For most people asking about alternatives, the honest list is short: semaglutide, or tirzepatide by a different route. Compounded tirzepatide and compounded semaglutide are not FDA approved and are not interchangeable with Zepbound, Mounjaro, Wegovy or Ozempic. A licensed provider decides whether a compounded medication is appropriate. FormBlends offers both compounded drugs; the assessment is where that decision is made, and availability for your address is confirmed before any charge.

Frequently Asked Questions

Is there a tirzepatide alternative over the counter?

No. Tirzepatide and semaglutide are prescription drugs. Supplements sold as natural versions do not contain either drug and have not been tested against them. Vials sold without a prescription are gray market products the FDA has warned about.

What is the closest medical alternative to tirzepatide?

Semaglutide. It is a once-weekly GLP-1 injection sold as Wegovy and Ozempic and also available compounded. In SURMOUNT-5 it produced 13.7% mean weight loss versus 20.2% for tirzepatide at 72 weeks.

Is semaglutide as good as tirzepatide for weight loss?

In the head-to-head trial, tirzepatide produced more weight loss. Semaglutide still produced a large loss compared with placebo in other trials. Which is right for you depends on tolerance, coverage and your prescriber's judgment.

Is compounded tirzepatide an alternative to Zepbound?

It is the same molecule by a different route, made per prescription by a state-licensed 503A compounding pharmacy. It is not FDA approved, not interchangeable with Zepbound, and has no trial data of its own. A licensed provider decides whether it is appropriate.

Can diet and exercise replace tirzepatide?

In SURMOUNT-3, people who had already done a 12-week lifestyle program gained 2.5% on placebo while those who added tirzepatide lost a further 18.4%. Lifestyle change is part of every plan, but in the trials it did not match the drug on its own.

Sources

1. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5), Aronne et al., New England Journal of Medicine, 2025.
2. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2), Frias et al., New England Journal of Medicine, 2021.
3. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1), Jastreboff et al., New England Journal of Medicine, 2022.
4. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3), Wadden et al., Nature Medicine, 2023.
5. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4), Aronne et al., JAMA, 2024.
6. Zepbound (tirzepatide) prescribing information, DailyMed, National Library of Medicine, revised 08/2026.
7. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, U.S. Food and Drug Administration.
8. FormBlends pricing, Form Blends LLC, verified September 5, 2026.

Next steps

For the full comparison, read semaglutide vs tirzepatide. For the brand versus compounded question, see compounded tirzepatide vs Mounjaro, and for every price in one place, the tirzepatide cost guide. Browse the tirzepatide hub for every other tirzepatide question. Talk to a clinician before you choose or switch any of these drugs. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro; a licensed provider decides whether it is appropriate for you.